Orofacial Pain and Snoring/Obstructive Sleep Apnea in Individuals with Head and Neck Cancer: A Critical Review

Aims: (1) To summarize current knowledge on the prevalence, intensity, and descriptors of orofacial pain and snoring/obstructive sleep apnea (OSA) before and after head and neck cancer (HNC) treatment; and (2) to propose future directions for research. Methods: The median prevalence for each condition was estimated from the most recent systematic reviews (SRs) and updated with new findings retrieved from the PubMed, Web of Science, Embase, and Cochrane databases up to December 2021. Results: The prevalence of HNC pain seems relatively stable over time, with a median of 31% before treatment in three studies to a median of 39% at 1 month to 16 years after treatment in six studies. HNC pain intensity remains mild to moderate. There was a threefold increase in temporomandibular pain prevalence after surgery (median 7.25% before to 21.3% after). The data for snoring prevalence are unreliable. The OSA/HNC prevalence seems relatively stable over time, with a median of 72% before treatment in three studies to 77% after treatment in 14 studies. Conclusion: With the exception of temporomandibular pain, the prevalence of HNC pain and OSA seems to be stable over time. Future studies should: (1) compare the trajectory of change over time according to each treatment; (2) compare individuals with HNC to healthy subjects; (3) use a standardized and comparable method of data collection; and (4) assess tolerance to oral or breathing devices, since HNC individuals may have mucosal sensitivity or pain.

head and neck cancer; orofacial pain; prevalence; sleep apnea; snoring

1. Timbang MR, Sim MW, Bewley AF, et al. HPV-related oropharyngeal cancer: A review on burden of the disease and opportunities for prevention and early detection. Hum Vaccin Immunother 2019;15:1920–1928.

2. Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer 2017;123:2219–2229.

3. National Institute of Dental and Craniofacial Research. Oral health in America. Reviewed May 2022. https://www.nidcr.nih. gov/research/oralhealthinamerica. Accessed 18 May 2022.

4. Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:56–61.

5. Lam DK, Schmidt BL. Orofacial pain onset predicts transition to head and neck cancer. Pain 2011;152:1206–1209.

6. Epstein JB, Hong C, Logan RM, et al. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 2010;18:1023–1031.

7. Rogers SN, Cleator AJ, Lowe D, Ghazali N. Identifying pain-related concerns in routine follow-up clinics following oral and oropharyngeal cancer. World J Clin Oncol 2012;3:116–125.

8. Pauli N, Mejersjö C, Fagerberg-Mohlin B, Finizia C. Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms. Head Neck 2019;41:3570–3576.

9. Macfarlane TV, Wirth T, Ranasinghe S, Ah-See KW, Renny N, Hurman D. Head and neck cancer pain: systematic review of prevalence and associated factors. J Oral Maxillofac Res 2012;3:e1.

10. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007;18:1437–1449.

11. Nicot R, Raoul G, Ferri J, Schlund M. Temporomandibular disorders in head and neck cancers: Overview of specific mechanisms and management. J Stomatol Oral Maxillofac Surg 2020;121:563–568.

12. Romero-Reyes M, Salvemini D. Cancer and orofacial pain. Med Oral Patol Oral Cir Bucal 2016;21:e665–e671.

13. Bossi P, Ghiani M, Argenone A, Depenni R. Is pain part of a systemic syndrome in head and neck cancer? Support Care Cancer 2020;28:451–459.

14. Viet CT, Schmidt BL. Schmidt, Biologic mechanisms of oral cancer pain and implications for clinical therapy. J Dent Res 2012;91:447–453.

15. Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in cancer: Part I–mechanisms. J Dent Res 2007;86:491–505.

16. Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: Part II–clinical perspectives and management. J Dent Res 2007;86:506–518.

17. Fischer DJ, Klasser GD, Epstein JB. Cancer and orofacial pain. Oral Maxillofac Surg Clin North Am 2008;20:287–301, vii.

18. Mirabile A, Airoldi M, Ripamonti C, et al. Pain management in head and neck cancer patients undergoing chemoradio-therapy: Clinical practical recommendations. Crit Rev Oncol Hematol 2016;99:100–106.

19. Chen SY, Massa S, Mazul AL, et al. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review. Am J Otolaryngol 2020;41:102592.

20. Chua KS, Reddy SK, Lee MC, Patt RB. Pain and loss of function in head and neck cancer survivors. J Pain Symptom Manage 1999;18:193–202.

21. Terkawi AS, Tsang S, Alshehri AS, Mulafikh DS, Alghulikah AA, AlDhahri SF. The burden of chronic pain after major head and neck tumor therapy. Saudi J Anaesth 2017;11(suppl 1):s71–s79.

22. Cho SF, Rau KM, Shao YY, et al. Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: A multi-center study. Support Care Cancer 2019;27:1663–1672.

23. Morin CM, Drake CL, Harvey AG, et al. Insomnia disorder. Nat Rev Dis Primers 2015;1:15026.

24. Olfson M, Wall M, Liu SM, Morin CM, Blanco C. Insomnia and impaired quality of life in the United States. J Clin Psychiatry 2018;79:17m12020.

25. Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: An 18-month longitudinal study. J Clin Oncol 2011;29:3580–3586.

26. Santoso AMM, Jansen F, de Vries R, Leemans CR, van Straten A, Verdonck-de Leeuw IM. Prevalence of sleep disturbances among head and neck cancer patients: A systematic review and meta-analysis. Sleep Med Rev 2019;47:62–73.

27. Yaremchuk K. Why and when to treat snoring. Otolaryngol Clin North Am 2020;53:351–365.

28. De Meyer MMD, Jacquet W, Vanderveken OM, Marks LAM. Systematic review of the different aspects of primary snoring. Sleep Med Rev 2019;45:88–94.

29. Patel JA, Ray BJ, Fernandez-Salvador C, Gouveia C, Zaghi S, Camacho M. Neuromuscular function of the soft palate and uvula in snoring and obstructive sleep apnea: A systematic review. Am J Otolaryngol 2018;39:327–337.

30. Acar M, Yazıcı D, Bayar Muluk N, Hancı D, Seren E, Cingi C. Is there a relationship between snoring sound intensity and frequency and OSAS severity? Ann Otol Rhinol Laryngol 2016;125:31–36.

31. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: A review. JAMA 2020;323:1389–1400.

32. Niu Y, Sui X, He Y, et al. Association between self-reported snoring and hypertension: A systematic review and meta-analysis. Sleep Med 2021;88:140–148.

33. Bai J, He B, Wang N, et al. Snoring is associated with increased risk of stroke: A cumulative meta-analysis. Front Neurol 2021;12:574649.

34. Liu J, Shao Y, Bai J, et al. Snoring increases the development of coronary artery disease: A systematic review with meta-analysis of observational studies. Sleep Breath 2021;25:2073–2081.

35. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006–1014.

36. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respir Med 2015;3:310–318.

37. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010;11:441–446.

38. Benjafield AV, Ayas NT, Eastwood PR Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. Lancet Respir Med 2019;7:687–698.

39. Ralli M, Campo F, Angeletti D, et al. Obstructive sleep apnoea in patients treated for head and neck cancer: A systematic review of the literature. Medicina (Kaunas) 2020;56:399.

40. Gavidia R, Dunietz GL, O’Brien L, et al. Obstructive sleep apnea in patients with head and neck cancer: A systematic review. J Clin Sleep Med 2021;17:1109–1116.

41. Havard M, Esslinger H, Mierzwa M, Kharofa J, Takiar V. Increased pain reporting by head and neck cancer patients at radiation oncology consultation: A quality-of-life analysis. Laryngoscope 2021;131:326–332.

42. Pegoraro DR, Zanchet B, Guariente CO, Rocha JP, Batista JS. Analysis of the frequency and degree of temporomandibular disorder in patients with head and neck cancer undergoing radiotherapy. Fisioter Mov 2016;29:361–368. 43.

43. Hu ZY, Feng XQ, Fu MR, Yu R, Zhao HL. Symptom patterns, physical function and quality of life among head and neck cancer patients prior to and after surgical treatment: A prospective study. Eur J Oncol Nurs 2020;46:101770.

44. Saghafi E, Tuomi L, Kjeller G. The prevalence and symptoms of temporomandibular disorders in head and neck cancer patients. Acta Odontol Scand 2022;80:252–257.

45. Lou DI, Dietrich MS, Deng J, Murphy BA. Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes. Head Neck 2021;43:3720–3729.

46. Shuman AG, Terrell JE, Light E, et al. Predictors of pain among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2012;138:1147–1154.

47. Magaña LC, Murati S, Riffitts M, et al. Subjective and objective measures in assessing neck disability and pain in head and neck cancer. Laryngoscope 2021;131:2015–2022.

48. López E, de la Torre-Luque A, Lazo A, Álvarez J, Buela-Casal G. Assessment of sleep disturbances in patients with cancer: Cross-sectional study in a radiotherapy department. Eur J Oncol Nurs 2016;20:71–76.

49. Faiz SA, Balachandran D, Hessel AC, et al. Sleep-related breathing disorders in patients with tumors in the head and neck region. Oncologist 2014;19:1200–1206.

50. Lin HC, Friedman M, Chang HW, Fang FM, Lin MC, Su MC. Impact of head and neck radiotherapy for patients with naso-pharyngeal carcinoma on sleep-related breathing disorders. JAMA Otolaryngol Head Neck Surg 2014;140:1166–1172.

51. Loth A, Michel J, Giorgi R, et al. Prevalence of obstructive sleep apnoea syndrome following oropharyngeal can-cer treatment: A prospective cohort study. Clin Otolaryngol 2017;42:1281–1288.

52. Tawfik GM, Mostafa EM, Alshareef A, et al. Association between radiotherapy and obstructive sleep apnea in head and neck cancer patients: A systematic review and meta-analysis. Auris Nasus Larynx 2021;48:1126–1134.

53. Saesen K, van der Veen J, Buyse B, Nuyts S. Obstructive sleep apnea in head and neck cancer survivors. Support Care Cancer 2021;29:279–287.

54. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191–197.

55. Cooperstein E, Gilbert J, Epstein JB, et al. Vanderbilt Head and Neck Symptom Survey version 2.0: Report of the devel-opment and initial testing of a subscale for assessment of oral health. Head Neck 2012;34:797–804.

56. Rogers SN, Lowe D, Brown JS, Vaughan ED. A comparison between the University of Washington Head and Neck Disease-Specific measure and the Medical Short Form 36, EORTC QOQ-C33 and EORTC Head and Neck 35. Oral Oncol 1998;34:361–372.

57. Rogers SN, Lowe D, Brown JS, Vaughan ED. The University of Washington head and neck cancer measure as a predictor of outcome following primary surgery for oral cancer. Head Neck 1999;21:394–401.

58. Rogers SN, O’donnell JP, Williams-Hewitt S, Christensen JC, Lowe D. Health-related quality of life measured by the UW-QoL–reference values from a general dental practice. Oral Oncol 2006;42:281–287.

59. Viala-Danten M, Martin S, Guillemin I, Hays RD. Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial. Health Qual Life Outcomes 2008;6:113.

60. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133–137.

61. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19:306–314.

62. Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O’Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med 1997;20:589–605.

63. Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck 2007;29:923–931.

64. Helkimo M. Studies on function and dysfunction of the masticatory system. II. Index for anamnestic and clinical dysfunction and occlusal state. Sven Tandlak Tidskr 1974;67:101–121.

65. Johnson J, Carlsson S, Johansson M, et al. Development and validation of the Gothenburg Trismus Questionnaire (GTQ). Oral Oncol 2012;48:730–736.

66. Paz García-Portilla M, Sáiz PA, Díaz-Mesa EM, et al. Psychometric performance of the Oviedo Sleep Questionnaire in patients with severe mental disorder. Rev Psiquiatr Salud Ment 2009;2:169–177.

67. Steffen A, Graefe H, Gehrking E, König IR, Wollenberg B. Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol 2009;129:1300–1305.

68. Pevernagie DA, Gnidovec-Strazisar B, Grote L, et al. On the rise and fall of the apnea-hypopnea index: A historical review and critical appraisal. J Sleep Res 2020;29:e13066.

69. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache 2014;28:6–27.

70. Painter JR, Seres JL, Newman RI. Assessing benefits of the pain center: Why some patients regress. Pain 1980;8:101–113.

71. Scott J, Huskisson EC. Accuracy of subjective measurements made with or without previous scores: An important source of error in serial measurement of subjective states. Ann Rheum Dis 1979;38:558–559.

72. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001;8:1153–1157.

73. Stöberl AS, Schwarz EI, Haile SR, et al. Night-to-night variability of obstructive sleep apnea. J Sleep Res 2017;26:782–788.

74. Roeder M, Bradicich M, Schwarz EI, Thiel S, Gaisl T, Held U, Kohler M. Night-to-night variability of respiratory events in ob-structive sleep apnoea: A systematic review and meta-analysis. Thorax 2020;75:1095–1102.

75. Tan BKJ, Teo YH, Tan NKW, et al. Association of obstructive sleep apnea and nocturnal hypoxemia with all-cancer incidence and mortality: A systematic review and meta-analysis. J Clin Sleep Med 2022;18:1427–1440.

76. Pack AI, Magalang UJ, Singh B, Kuna ST, Keenan BT, Maislin G. Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: Understanding and overcoming bias. Sleep 2021;44:zsaa229.

77. Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: Propensity score matching and its alternatives. Eur J Cardiothorac Surg 2018;53:1112–1117.

78. Reiffel JA. Propensity score matching: The ‘devil is in the details’ where more may be hidden than you know. Am J Med 2020;133:178–181.

79. Senaratna CV, Perret JL, Lodge CJ, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev 2017;34:70–81.

80. Rosen IM, Aurora RN, Kirsch DB, et al. Chronic opioid therapy and sleep: An American Academy of Sleep Medicine position statement. J Clin Sleep Med 2019;15:1671–1673.

81. Lavigne GJ, Herrero Babiloni A, Mayer P, Daoust R, Martel MO. Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep. J Clin Sleep Med 2020;16:831–833.

82. Reynor A, McArdle N, Shenoy B, et al. Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: Are participants of randomized trials representative of sleep clinic patients? Sleep 2022;45:zsab264.

83. Serrano-García B, Bartrina-Rodríguez I, Zubeldia-Varela JM, et al. Preliminary study of the Craniofacial Pain and Disability Inventory-11: Validation for patients with head and neck cancer. Med Oral Patol Oral Cir Bucal 2021;26:e661–e668.

84. Borges REA, Mendonça LDRA, Dos Santos Calderon P. Diagnostic and screening inventories for temporomandibular disorders: A systematic review. Cranio 2021. Epub ahead of print 18 July.85.

85. Alakuijala A, Salmi T. Predicting obstructive sleep apnea with periodic snoring sound recorded at home. J Clin Sleep Med 2016;12:953–958.

86. Sowho M, Sgambati F, Guzman M, Schneider H, Schwartz A. Snoring: A source of noise pollution and sleep apnea predic-tor. Sleep 2020;43:zsz305.

87. Phipps AI, Bhatti P, Neuhouser ML, et al. Prediagnostic sleep duration and sleep quality in relation to subsequent cancer survival. J Clin Sleep Med 2016;12:495–503.

88. Carberry JC, Amatoury J, Eckert DJ. Personalized Management Approach for OSA. Chest 2018;153:744–755.

89. Chung F, Yegneswaran B, Liao P, et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 2008;108:822–830.

90. Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: A bivariate meta-analysis. Sleep Med Rev 2017;36:57–70.

91. Tentindo GS, Fishman SM, Li CS, Wang Q, Brass SD. The prevalence and awareness of sleep apnea in patients suffering chronic pain: An assessment using the STOP-Bang sleep apnea questionnaire. Nat Sci Sleep 2018;10:217–224.

92. Laharnar N, Herberger S, Prochnow LK, et al. Simple and unbiased OSA prescreening: Introduction of a new morphologic OSA prediction score. Nat Sci Sleep 2021;13:2039–2049.

93. Mutlu M, Korkmaz MH, Simsek E, et al. Do CO2 and oxidative stress induce cancer?: A brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients. J Enzyme Inhib Med Chem 2019;34:459–464.

94. Selvanathan J, Waseem R, Peng P, Wong J, Ryan CM, Chung F. Simple screening model for identifying the risk of sleep apnea in patients on opioids for chronic pain. Reg Anesth Pain Med 2021;46:886–891.